Full text is available at the source.
Abstract
Patients undergoing foot and ankle surgery frequently have comorbidities like diabetes, obesity, and vascular disease.
- These comorbidities may heighten the risk of postoperative complications.
- The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is becoming more common in this patient population.
- Understanding the perioperative effects of GLP-1 RAs is important due to their increasing prevalence.
Simplified